Cyclodextrin Antiseptic Wound Dressing for Sustained Exudate Resistance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing antiseptic materials for wound dressings lose effectiveness quickly due to dilution by wound exudate and require frequent changes, which hinder wound healing, especially in vacuum-assisted wound management.

Innovation Solution

A carrier material finished with cyclodextrin or cyclodextrin derivatives loaded with antiseptics and surfactants, such as polyhexanide and betaine, provides sustained antibacterial activity by stabilizing the antiseptics and promoting wound healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antiseptic materials are used in wound dressings, then antibacterial effect is achieved, but the effect is exhausted after relatively short time due to dilution by wound exudate and removal with exudate

Engineering Contradiction:
Improveantibacterial effect durabilityVSAvoidduration of antiseptic activity
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent embeds antiseptic molecules within cyclodextrin cavity structures, creating an inclusion complex where the antiseptic is nested inside the cyclodextrin. This nested structure protects the antiseptic from dilution and premature release, allowing sustained activity over time while maintaining reliable antibacterial effect.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The cyclodextrin is pre-loaded with antiseptic molecules during the finishing process, creating a reservoir of active substance on the carrier material before contact with wound exudate. This preliminary loading ensures that the antiseptic is available for gradual release over an extended period, rather than being immediately diluted and removed.

Inventive Principle:
Principle #10Preliminary action

2Object-affected harmful factors

If absorbent material is impregnated with antiseptic for vacuum-assisted wound management, then antibacterial protection is improved, but the antiseptic is sucked out of the wound together with exudate within entirely short time

Engineering Contradiction:
Improvewound infection riskVSAvoidantiseptic retention time
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of moving object

Solution Approach 1:

The antiseptic is nested within the cyclodextrin inclusion complex on the absorbent material, creating a protected reservoir that prevents rapid extraction by vacuum suction. The nested structure allows controlled release rather than complete removal, extending the duration of antibacterial protection.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The cyclodextrin acts as an intermediary carrier between the absorbent material and the wound exudate. It mediates the release of antiseptic molecules, preventing direct extraction by the vacuum while still allowing gradual diffusion to the wound surface for sustained infection protection.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If frequent change of wound dressing is carried out to maintain antiseptic effectiveness, then antibacterial activity is maintained, but the healing process is hindered

Engineering Contradiction:
Improveantibacterial activity maintenanceVSAvoidwound healing rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The cyclodextrin is pre-loaded with sufficient antiseptic capacity during manufacturing to provide extended coverage. This preliminary action eliminates the need for frequent dressing changes, allowing the wound to heal undisturbed while maintaining reliable antibacterial activity throughout the extended wear period.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The cyclodextrin-antiseptic complex provides continuous, sustained release of antibacterial activity over an extended period. This continuous action maintains protection without interruption or need for frequent replacement, allowing uninterrupted wound healing progress.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The antiseptic material maintains effectiveness over time, reduces toxicity, and supports wound healing by inhibiting biofilms, absorbing exudate, and creating an optimal pH environment, while being biocompatible and durable.

Implementation Method 1

the carrier material is finished with a cyclodextrin or cyclodextrin derivative, which is loaded with the antiseptic or with several antiseptics

Methodology Applied
Scientific EffectInclusion complex formation: Solvation

Implementation Method 2

one or more antiseptics and a surfactant

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Data Source

PatentUS12491284B2Antiseptic wound dressing
Publication Date: 2025.12.09 HAWEST RES
  • US12491284B2 patent drawing

AI summary

The invention relates to an antiseptic material, in particular as a wound dressing, containing a carrier material and at least one antiseptic together with a surfactant, wherein the carrier material is equipped with a cyclodextrin or cyclodextrin derivative that is loaded in the antiseptic or antiseptics.